Pamrevlumab in idiopathic pulmonary fibrosis

Lancet Respir Med. 2020 Jan;8(1):2-3. doi: 10.1016/S2213-2600(19)30339-X. Epub 2019 Sep 28.

Author

Athol U Wells¹

Affiliation

¹ Royal Brompton Hospital, London SW3 6HP, UK. Electronic address: rbhild@rbht.nhs.uk.

PMID: 31575507
DOI: 10.1016/S2213-2600(19)30339-X

No abstract available

Publication types

Comment

MeSH terms

Double-Blind Method
Humans
Idiopathic Pulmonary Fibrosis*